Pages that link to "Q37323255"

The following pages link to Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. (Q37323255):

Displaying 28 items.

• Role of RUNX2 in Breast Carcinogenesis (Q28084968) (← links)
• RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland (Q33555996) (← links)
• Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells (Q33808162) (← links)
• Metastatic bone disease: role of transcription factors and future targets (Q34217531) (← links)
• Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility (Q34989177) (← links)
• Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters. (Q35181201) (← links)
• Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease (Q35251618) (← links)
• Myeloma cell-derived Runx2 promotes myeloma progression in bone. (Q35692401) (← links)
• Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness (Q35751787) (← links)
• Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility (Q35762938) (← links)
• RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells (Q36413997) (← links)
• Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells (Q36937029) (← links)
• The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells (Q36947310) (← links)
• MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma (Q37175182) (← links)
• Regulation of breast cancer and bone metastasis by microRNAs (Q37259128) (← links)
• The RUNX family in breast cancer: relationships with estrogen signaling (Q38050410) (← links)
• RUNX2 in mammary gland development and breast cancer. (Q38061373) (← links)
• The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition (Q38744455) (← links)
• Runx Genes in Breast Cancer and the Mammary Lineage. (Q39181420) (← links)
• Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor (Q39384202) (← links)
• Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells (Q39801788) (← links)
• Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity (Q42378493) (← links)
• Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas (Q42533014) (← links)
• Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer (Q46122438) (← links)
• Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma (Q46303094) (← links)
• Runx2 in human breast carcinoma: its potential roles in cancer progression (Q54643065) (← links)
• Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer (Q86573068) (← links)
• Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression (Q88204157) (← links)